8-K current report · filed Oct 14, 2026

MAXCYTE, INC. (MXCT) 8-K Current Report: October 14, 2026

Item 2.02Item EX-99.1MXCT overview

Short answer

MAXCYTE, INC. (MXCT) filed an 8-K current report with the SEC on October 14, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Preliminary unaudited revenue results for quarter ended September 30, 2026.

MAXCYTE, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Preliminary unaudited revenue results for quarter ended September 30, 2026
  • Full-year 2026 revenue guidance increased, signaling stronger expected business performance
  • Results remain subject to quarter-end close and interim financial statement review
  • Independent auditor has not reviewed or audited the preliminary figures
  • Exhibit 99.1 contains the revenue figures and updated guidance details

Item EX-99.1 · Exhibit EX-99.1

  • Preliminary Q3 core revenue $8.1M, up 26% year over year, signaling resumed growth
  • SPL program revenue exceeded $1.0M, including a $1.0M milestone payment
  • FY2026 revenue guidance raised to approximately $34M from prior $30M-$32M
  • FY2026 core revenue guidance increased to approximately $28M, up from $25M-$27M
  • SPL guidance raised to approximately $6M, including $4M milestones and $2M royalties

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other MAXCYTE, INC. 8-K filings

Get the next MXCT 8-K as it lands

Follow MXCT for push alerts, or ask the research agent what this filing means.